• Historically, they have been most commonly divided by the stage of maturation at which the clonal (neoplastic) lymphoid population stopped maturing:[citation needed] Acute lymphoblastic leukemia Chronic lymphocytic leukemia However, the influential WHO Classification (published in 2001) emphasized a greater emphasis on cell lineage. (wikipedia.org)
  • To this end, lymphoid leukemias can also be divided by the type of cells affected: B-cell leukemia T-cell leukemia NK-cell leukemia The most common type of lymphoid leukemia is B-cell chronic lymphocytic leukemia. (wikipedia.org)
  • What is the difference between acute and chronic leukemia? (mdanderson.org)
  • Depending on the type of stem cells damaged and when the breakdown in their growth occurs, leukemia can be classified into two groups: acute or chronic. (mdanderson.org)
  • Our Elias Jabbour, M.D. , shares the differences in acute and chronic leukemias, including how they're subtyped and how that helps determine treatment. (mdanderson.org)
  • Chronic leukemia results from a failure in the life cycle after the cells have matured. (mdanderson.org)
  • Beyond chronic and acute, a leukemia diagnosis can be further defined by determining which of the two types of stem cells are affected: lymphoid cells or myeloid cells. (mdanderson.org)
  • Do the symptoms differ between chronic and acute leukemias? (mdanderson.org)
  • Yes, chronic leukemias develop slowly, so most patients don't experience as many symptoms . (mdanderson.org)
  • See Chronic Leukemias: 4 Cancers to Differentiate , a Critical Images slideshow, for images and information on CLL identification and treatment. (medscape.com)
  • EVs were isolated from the serum of acute myeloid leukemia (AML), acute lymphoid leukemia (ALL), chronic lymphoid leukemia (CLL) patients, and healthy volunteers. (nature.com)
  • Chronic lymphocytic leukemia (CLL) is a monoclonal disorder characterized by a progressive proliferation and accumulation of mature yet functionally incompetent lymphocytes. (medscape.com)
  • Peripheral smear from a patient with chronic lymphocytic leukemia, small lymphocytic variety. (medscape.com)
  • Chronic lymphocytic leukemia ( CLL ) is a type of cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell ). (wikipedia.org)
  • Pick AM. Pick A.M. Pick, Amy M. Chronic Leukemias and Multiple Myeloma. (mhmedical.com)
  • Explain the role of the Philadelphia chromosome in the pathophysiology of chronic myelogenous leukemia (CML). (mhmedical.com)
  • Identify the clinical signs and symptoms and laboratory findings associated with CML, chronic lymphocytic leukemia (CLL), and multiple myeloma (MM). (mhmedical.com)
  • S everal diseases comprise chronic leukemia. (mhmedical.com)
  • The two most common forms are chronic myelogenous leukemia (CML) and chronic lymphocytic leukemia (CLL). (mhmedical.com)
  • The slower progression of the disease contrasts it from acute leukemia, with the survival of chronic leukemia often lasting several years without treatment. (mhmedical.com)
  • There are many types of chronic leukemias. (ldc-phila-vic.org)
  • Chronic leukemia involves more-mature blood cells. (ldc-phila-vic.org)
  • Some forms of chronic leukemia initially produce no early symptoms and can go unnoticed or undiagnosed for years. (ldc-phila-vic.org)
  • With CLL , the most common chronic adult leukemia, you may feel well for years without needing treatment. (ldc-phila-vic.org)
  • Hairy cell leukemia (HCL) is certainly a chronic lymphoproliferative disorder seen as a somatic recently discovered somatic inhibition in hematopoiesis inside our murine choices aswell as in individuals with in HCL individuals we performed quantitative sequencing of the spot of ITD-1 p. (academicediting.org)
  • Classical Hairy Cell Leukemia (HCL) and HCL-like disorders are a very heterogeneous group of mature B-cell Chronic Lympho proliferative Disorders (B-CLPD). (fortuneonline.org)
  • Patients with chronic lymphocytic leukemia (chronic lymphoid leukemia, CLL) present with a wide range of symptoms and signs. (medscape.com)
  • Chronic Lymphocytic Leukemia Treatment (PDQ®): Health Professional Version. (medscape.com)
  • Klepfish A, Gilles L, Ioannis K, Eliezer R, Ami S. Enhancing the action of rituximab in chronic lymphocytic leukemia by adding fresh frozen plasma: complement/rituximab interactions & clinical results in refractory CLL. (medscape.com)
  • A polymorphism and disease progression in chronic lymphocytic leukemia. (medscape.com)
  • Investigating the targets of MIR-15a and MIR-16-1 in patients with chronic lymphocytic leukemia (CLL). (medscape.com)
  • Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. (medscape.com)
  • SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. (medscape.com)
  • Familial Chronic Lymphocytic Leukemia: What Does it Mean to Me? (medscape.com)
  • Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia. (medscape.com)
  • Improved survival in chronic lymphocytic leukemia in the past decade: a population-based study including 11,179 patients diagnosed between 1973-2003 in Sweden. (medscape.com)
  • Chronic lymphocytic leukemia (CLL) is characterized by progressive accumulation of phenotypically mature malignant B lymphocytes. (msdmanuals.com)
  • Chronic lymphocytic leukemia is the most common type of leukemia in the Western world. (msdmanuals.com)
  • In chronic lymphocytic leukemia, CD5+ B cells undergo malignant transformation. (msdmanuals.com)
  • Chronic lymphocytic leukemia (chronic lymphoid leukemia, CLL) is a monoclonal disorder characterized by a progressive accumulation of functionally incompetent lymphocytes (see the image below). (medscape.com)
  • See Chronic Leukemias: 4 Cancers to Differentiate , a Critical Images slideshow, to help detect chronic leukemias and determine the specific type present. (medscape.com)
  • How do lymphoid cells or myeloid cells fit into a leukemia diagnosis? (mdanderson.org)
  • See also Pediatric Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia (AML) . (medscape.com)
  • This mechanism also applies to hematopoietic cells transformed by other HOX genes, including CDX2, which is highly expressed in a majority of acute myeloid leukemias, thus providing a molecular approach based on GSK-3 inhibitory strategies to target HOX-associated transcription in a broad spectrum of leukemias. (stanford.edu)
  • CML is a hematologic cancer that results from an abnormal proliferation of an early myeloid progenitor cell. (mhmedical.com)
  • This type of leukemia affects the myeloid cells. (ldc-phila-vic.org)
  • Even though stem cell source for myeloid malignancies such as myeloproliferative neoplasms myelodysplastic syndromes and acute myeloid leukemia (AML) is definitely well established a link between aberrations in HSPCs and development of mature lymphoid malignancies has been less thoroughly investigated. (academicediting.org)
  • Latest genomic analyses of leukemias of another lymphoid lineage T cell severe lymphoblastic leukemia (T-ALL) uncovered that a particular subset of T-ALL is normally highly similar on track and myeloid leukemic HSCs in gene appearance and mutational profile (25). (academicediting.org)
  • Further transplantation experiments demonstrated that lympho-myeloid progenitors (LMPPs) allowed the propagation of pMIRH-130b mixed B-cell/myeloid leukemia, whereas Lin-Sca1 +/− Il7 + Kit + blasts maintained pro-B-ALL disease of pMIRH-128a mice. (ashpublications.org)
  • Leukemia and lymphoma are blood malignancies that affect people of all ages and result in approximately 23,000 deaths in the United States per year [ 1 ]. (nature.com)
  • Effective immune surveillance of patients with hematologic malignancies such as leukemia is mediated by cellular and noncellular arms of the innate and adaptive immune system. (nature.com)
  • The most common childhood malignancies are acute lymphoblastic leukemia, central nervous system (CNS) tumors and lymphomas. (aafp.org)
  • Collectively these results claim that genomic and useful analyses of lymphoid malignancies may reveal unforeseen alterations in much less differentiated HSPC populations. (academicediting.org)
  • Since CD2 is present in most precursor and mature T-cell leukemias and lymphomas, it is useful in the evaluation of lymphoid malignancies. (attogene.com)
  • The lymphocytic leukemias are closely related to lymphomas of the lymphocytes, to the point that some of them are unitary disease entities that can be called by either name (for example, adult T-cell leukemia/lymphoma). (wikipedia.org)
  • It causes 15% of acute leukemias in childhood, and also 40% of lymphomas in childhood. (wikipedia.org)
  • Leukemias, lymphomas and central nervous system tumors account for more than one half of new cancer cases in children. (aafp.org)
  • Our research focuses on developmental pathways that regulate hematopoietic cell growth and differentiation and are disrupted in the course of neoplastic transformation, particularly in leukemias and lymphomas. (stanford.edu)
  • It is a clonal genetic heterogeneous disease generally thought to arise from the malignant transformation and expansion of a single lymphoid progenitor at various stages of development ( 3 - 5 ). (frontiersin.org)
  • Acute lymphocyte leukemia is malignant disorder arising from a single lymphoid stem cell, with impaired maturation and accumulation of the malignant cells in the bone marrow. (slideshare.net)
  • Other types include (with ICD-O code): 9826/3 - Acute lymphoblastic leukemia, mature B-cell type 9833/3 - B-cell prolymphocytic leukemia 9940/3 - Hairy cell leukemia T-cell leukemia describes several different types of lymphoid leukemias which affect T cells. (wikipedia.org)
  • citation needed] The most common T-cell leukemia is precursor T-cell lymphoblastic leukemia. (wikipedia.org)
  • Its morphology is identical to that of precursor B-cell lymphoblastic leukemia. (wikipedia.org)
  • Acute lymphoblastic leukemia (acute lymphocytic leukemia, ALL) is a malignant (clonal) disease of the bone marrow in which early lymphoid precursors proliferate and replace the normal hematopoietic cells of the marrow. (medscape.com)
  • The image below shows pre-B-cell lymphoblastic leukemia/lymphoma (B-ALL). (medscape.com)
  • Acute lymphoblastic leukemia (ALL): Bone marrow shows proliferation of large and heterogeneous lymphoblasts consistent with pre-B-cell ALL (French-American-British L2 morphology). (medscape.com)
  • See the Childhood Acute Lymphoblastic Leukemia: Diagnosis, Management, and Complications slideshow to help recognize and treat this disease and its associated complications. (medscape.com)
  • The last decade has witnessed great advances in our understanding of the genetic and biological basis of childhood acute lymphoblastic leukemia (ALL), the development of experimental models to probe mechanisms and evaluate new therapies, and the development of more efficacious treatment stratification. (haematologica.org)
  • Several lines of evidence indicate that there is a genetic predisposition to acute lymphoblastic leukemia (ALL), at least in a subset of cases. (haematologica.org)
  • Immunoglobulin Heavy Chain High-Throughput Sequencing in Pediatric B-Precursor Acute Lymphoblastic Leukemia: Is the Clonality of the Disease at Diagnosis Related to Its Prognosis? (frontiersin.org)
  • High-throughput sequencing (HTS) of the immunoglobulin heavy chain ( IgH ) locus is a recent very efficient technique to monitor minimal residual disease of B-cell precursor acute lymphoblastic leukemia (BCP-ALL). (frontiersin.org)
  • B-cell precursor acute lymphoblastic leukemia (BCP-ALL) is the most common pediatric neoplasm ( 1 , 2 ). (frontiersin.org)
  • Translocations between MLL (a human trithorax -related gene) and AF4 or AF5q31 are involved in acute lymphoblastic leukemia (Wittwer, 2001, Tang, 2001 and Su, 2001). (sdbonline.org)
  • Global Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market - The Global Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market witnessed a rapid growth in the historic period from 2016 to 2019 and is anticipated to witness significant growth during the forecast period. (powershow.com)
  • Acute Lymphocytic / Lymphoblastic Leukemia Market - The acute lymphoblastic leukemia therapeutics market is segmented based on the existing regimens and drugs, pipeline drugs, and geography. (powershow.com)
  • Acute Lymphocytic/Lymphoblastic Leukemia Market worth $3.780.3 Million by 2020 - The "Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market - (Pipeline Forecast & Market Forecast in G8 Countries) (2010 - 2020)" analyzes and studies the major market drivers, restraints, and opportunities in the U.S., Canada, U.K., France, Germany, Italy, Spain, and Japan. (powershow.com)
  • 1 Mixed lineage leukemia (MLL) gene fusions are the molecular hallmark of infant acute lymphoblastic leukemia (ALL) and are present in tumor cells in up to 80% of patients. (ashpublications.org)
  • Cluster of differentiation 2 (CD2) is a useful early T-cell lineage restricted antigen that is present in T-cell differentiation. (attogene.com)
  • Lymphoid leukemias are a group of leukemias affecting circulating lymphocytes, a type of white blood cell. (wikipedia.org)
  • Most lymphoid leukemias involve a particular subtype of lymphocytes, the B cells. (wikipedia.org)
  • Lymphoid cells produce lymphocytes, which are white blood cells that make up a large part of the immune system. (mdanderson.org)
  • This type of leukemia affects the lymphoid cells (lymphocytes), which form lymphoid or lymphatic tissue. (ldc-phila-vic.org)
  • Lymphocytes initially accumulate in the bone marrow and then spread to lymph nodes and other lymphoid tissues, eventually inducing splenomegaly, hepatomegaly, and systemic symptoms such as fatigue, fever, night sweats, early satiety, and unintentional weight loss. (msdmanuals.com)
  • The malignant cells of ALL are lymphoid precursor cells (ie, lymphoblasts) that are arrested in an early stage of development. (medscape.com)
  • A majority of patients with NK cell leukemia die within a year of diagnosis, and for ANKL in particular, half of patients die within two months. (wikipedia.org)
  • Patients diagnosed early and/or with fewer risk factors can sometimes enter complete remission and expect much longer survival. (wikipedia.org)
  • However, patients with acute leukemias typically bleed easily, like when brushing their teeth. (mdanderson.org)
  • Risk-adapted therapies for AML, ALL, and CLL patients consist of chemotherapy with/without stem cell transplantation (SCT), but the rate of early failures and relapses is still unsatisfying. (nature.com)
  • Patients with early-stage CLL, including low Binet or Rai stages, are not treated with chemotherapy until they become symptomatic or display evidence of rapid progression of disease. (medscape.com)
  • In addition to these basic issues concerning leukemia pathogenesis, we are devising new diagnostic procedures for detecting and monitoring leukemia patients based on molecular genetic abnormalities in the malignant cells. (stanford.edu)
  • Only four cancer (kidney, melanoma, leukemia, and cervical cancer) patients reported a residential address at Pease Air Force Base between 1987 and 1991. (cdc.gov)
  • in this group of patients and the role of IFN- , a commonly mately 2-4% of lymphoid leukemias. (bvsalud.org)
  • Other types include: Large granular lymphocytic leukemia Adult T-cell leukemia/lymphoma T-cell prolymphocytic leukemia In practice, it can be hard to distinguish T-cell leukemia from T-cell lymphoma, and they are often grouped together. (wikipedia.org)
  • The diagnosis of Hairy Cell Leukemia and HCL-like diosrders, including HCL variant (vHCL) and Splenic Diffuse Red Pulp Lymphoma (SDRPL), is based on the examination of the peripheral blood and bone marrow smears allowing the identification of hairy cells and the flow cytometric analysis. (fortuneonline.org)
  • Splenic marginal zone lymphoma with circulating villous lymphoid cells (SMZL) is a distinct and very different pathological entity since the WHO 2008 classification: it is characterized by an expansion of the splenic white pulp with the infiltration of the red pulp. (fortuneonline.org)
  • Genetic subtypes of acute lymphoid leukemia were identified by using the Danish Registry of Childhood Cancer. (medscape.com)
  • Leukemia is cancer of the body's blood-forming tissues, including the bone marrow and the lymphatic system. (ldc-phila-vic.org)
  • INTRODUCTION:  Leukemia describes a group of malignant disorders in which uncontrolled proliferation of leucocyte in the bone marrow infiltrate the blood forming tissues of the bone marrow, lymph system, liver and spleen. (slideshare.net)
  • HCL is a well-defined entity in the 2017 revision of the World Health Organization (WHO) classification of the tumours of haematopoietic and lymphoid tissues. (fortuneonline.org)
  • Early initiation of chemotherapy has failed to show survival benefit in CLL. (medscape.com)
  • The chemotherapy drug regimens were dominated by Hyper-CVAD regimen sales, totaling $1.8 billion and linker regimen sales totaling $1.13 billion sales in acute lymphocytic leukemia market. (powershow.com)
  • People who've had certain types of chemotherapy and radiation therapy for other cancers have an increased risk of developing certain types of leukemia. (ldc-phila-vic.org)
  • The consolidation approach depends on how aggressive the leukemia is as well as the unique genetic characteristics of the diagnosis, which is determined through a series of tests at initial diagnosis. (mdanderson.org)
  • In general, leukemia is thought to occur when some blood cells acquire changes (mutations) in their genetic material or DNA. (ldc-phila-vic.org)
  • Targeting of Mll-AF4 in early fetal HSPCs enhanced the lymphoid potential of primed multipotent cells but was insufficient by itself to induce leukemia. (ashpublications.org)
  • Acute Lymphocytic Leukemia Drug Pipeline Analysis and Therapeutic Assessment, H2 2016 - Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Lymphocytic Leukemia Pipeline Review, H2 2016, provides an overview of the Acute Lymphocytic Leukemia (Oncology) pipeline landscape. (powershow.com)
  • Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Lymphocytic Leukemia Pipeline Review, H2 2016, provides an overview of the Acute Lymphocytic Leukemia (Oncology) pipeline landscape. (powershow.com)
  • Acute Lymphocytic Leukemia Therapeutics Market worth $3.88 Billion by 2020 - The acute lymphocytic leukemia therapeutics market was valued at $1.96 billion in 2010 and is expected to reach $3.88 billion by 2020, at a CAGR of 5.21% between 2015 and 2020. (powershow.com)
  • Global Acute Lymphocytic Leukemia Market: Trend Analysis and Forecast to 2022 - The report on Acute Lymphocytic Leukemia Market by Infinium Global Research analyzes over the period of 2015 to 2022. (powershow.com)
  • This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in Global Acute Lymphocytic Leukemia Market. (powershow.com)
  • It will help a lot of decision makers to develop strategies and find new opportunities in the Global Acute Lymphocytic Leukemia Market. (powershow.com)
  • Lymphocytic leukemia. (ldc-phila-vic.org)
  • Acute leukemias induced by MLL chimeric oncoproteins are among the subset of cancers distinguished by a paradoxical dependence on GSK-3 kinase activity for sustained proliferation. (stanford.edu)
  • Early in the disease, leukemia may cause nonspecific symptoms similar to those of a viral infection. (aafp.org)
  • Leukemia should be suspected if persistent vague symptoms are accompanied by evidence of abnormal bleeding, bone pain, lymphadenopathy or hepatosplenomegaly. (aafp.org)
  • [2] [8] Early on, there are typically no symptoms. (wikipedia.org)
  • Leukemia symptoms vary, depending on the type of leukemia. (ldc-phila-vic.org)
  • Leukemia symptoms are often vague and not specific. (ldc-phila-vic.org)
  • You may overlook early leukemia symptoms because they may resemble symptoms of the flu and other common illnesses. (ldc-phila-vic.org)
  • Over time, these abnormal cells can crowd out healthy blood cells in the bone marrow, leading to fewer healthy white blood cells, red blood cells and platelets, causing the signs and symptoms of leukemia. (ldc-phila-vic.org)
  • A person with CML may have few or no symptoms for months or years before entering a phase in which the leukemia cells grow more quickly. (ldc-phila-vic.org)
  • 3. INTENSIFICATION OR CONSOLIDATION THERAPY: After complete induction is obtained, a period of intensified treatment is administered to eradicate residual leukemic cells, this is followed by delayed intensification to prevent emergence of resistant leukemia clones. (slideshare.net)
  • B-cell leukemia describes several different types of lymphoid leukemia which affect B cells. (wikipedia.org)
  • Aggressive NK-cell leukemia (ANKL) is a lymphoid leukemia that is a deficiency NK cells. (wikipedia.org)
  • The requirements for diagnosing ANKL are as follows: Immature-looking NK cells Certain immunophenotypes Germline configuration genes: TCR-β and IgH Restricted cytotoxicity The T-cell receptor (TCR) is an important factor when ANKL is being diagnosed along with T-cell leukemia. (wikipedia.org)
  • One problem when using NK cells in order to fight off lymphoid leukemia is the fact that it is hard to amount enough of them to be effective. (wikipedia.org)
  • If these cells stall in their development, it can result in leukemia. (mdanderson.org)
  • Leukemias are classified based on when the cells deviate from in their life cycle. (mdanderson.org)
  • 3) We are defining the properties of cancer stem cells that initiate and sustain the unique disease features of acute leukemias through the use of various adoptive animal models. (stanford.edu)
  • Leukemia usually involves the white blood cells. (ldc-phila-vic.org)
  • But in people with leukemia, the bone marrow produces an excessive amount of abnormal white blood cells, which don't function properly. (ldc-phila-vic.org)
  • In leukemia, the mutations tell the blood cells to continue growing and dividing. (ldc-phila-vic.org)
  • Doctors classify leukemia based on its speed of progression and the type of cells involved. (ldc-phila-vic.org)
  • In acute leukemia, the abnormal blood cells are immature blood cells (blasts). (ldc-phila-vic.org)
  • Moreover our use of granulocyte DNA as matched somatic cells may have obscured additional mutations acquired early in the hematopoietic compartment and present at related frequencies in granulocyte and HCL DNA. (academicediting.org)
  • DEFINITION: Leukemia is a malignant disease of blood forming organs of the body that results in uncontrolled growth of immature white blood cells. (slideshare.net)
  • 1. INDUCTION THERAPY: Induction aims at eradication of all leukemia blast cells, which permits the return of normal hematopoiesis. (slideshare.net)
  • Comparative transcriptomic analysis of tumor cells from diseased mice revealed the expression of several well-known MLL-rearranged leukemia-associated target genes, including Meis1 , Runx1 ( pMIRH-128a mice), HoxA9 , Flt3 ( pMIRH-130b mice), Cdk6 , and Bcl2 . (ashpublications.org)
  • There were an estimated 8430 new cases of CML diagnosed in 2018, accounting for 14% of all adult leukemias. (mhmedical.com)
  • Diagnosis is confirmed by bone marrow aspiration or biopsy, which typically shows different stages of lymphoid development. (slideshare.net)
  • Acute leukopenia, with almost total absence of granular leukocytes, leukoblastic groups and lymphoid tissue in the bone marrow, was reported in the case of a 36-year-old chemist who had worked with radium for 14 years (Reitter and Martland 1926). (cdc.gov)
  • Although the incidence of childhood cancers increased slightly in the early 1980s, there has been no substantial change in the incidence of major pediatric cancers since the mid-1980s. (aafp.org)
  • We demonstrate here that GSK-3 maintains the MLL leukemia stem cell transcriptional program by promoting the conditional association of CREB and its coactivators TORC and CBP with homedomain protein MEIS1, a critical component of the MLL-subordinate program, which in turn facilitates HOX-mediated transcription and transformation. (stanford.edu)
  • By using CD2 and CD25 staining, the recognition of systemic mastocytosis and mastocytic leukemia is supported. (attogene.com)
  • In exploratory analyses, the risk for leukemia became nonsignificant when the use of hormonal contraception ended more than 6 months before conception. (medscape.com)
  • Early-stage CLL in asymptomatic cases responds better to careful observation, as there is no evidence that early intervention treatment can alter the course of the disease. (wikipedia.org)
  • Women who have first intercourse at an early age, multiple sexual partners, or partners who have had multiple sexual partners are at increased risk for developing the disease. (cdc.gov)
  • Early satiety and/or abdominal discomfort may be related to an enlarged spleen. (medscape.com)
  • A nationwide cohort study in more than 1.1 million Danish children shows that the use of combined estrogen and progestin oral contraceptives in the 6 months before conception or during pregnancy is associated with a small increase in the risk for any type of childhood leukemia, particularly the nonlymphoid types. (medscape.com)
  • The authors emphasize that the absolute risk for childhood leukemia remains low and that the safety of hormonal contraceptives is not a major concern. (medscape.com)
  • Since almost no risk factors have been established for childhood leukemia, these findings suggest an important direction for future research into its causes and prevention. (medscape.com)
  • Familial predisposition specific to leukemia is uncommon but has resulted in the identification of predisposing non-silent variants that are also observed in sporadic ALL cases, including TP53 germline mutations and low hypodiploid B-ALL, ETV6 variants and hyperdiploid ALL, and PAX5 mutations and B-ALL with dicentric/isochromosome 9. (haematologica.org)